Fractyl Laboratories Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fractyl Laboratories Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10488
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fractyl Laboratories Inc (Fractyl) is a clinical-stage medical technology company that develops novel devices and procedures to overcome insulin resistance and restitute metabolic health. The company developed a device-based clinical platform to change the way of treating metabolic diseases. Fractyl developed Revita duodenal mucosal resurfacing (DMR), an investigational, minimally invasive, same-day clinical procedure that helps resolve the cause of insulin resistance in the duodenum in two common metabolic diseases, namely, type 2 diabetes and nonalcoholic steatohepatitis (NASH). The company is conducting clinical trials to demonstrate that the Revita DMR system procedure can improve glucose control and reduce the need for additional medications. Fractyl is headquartered in Lexington, Massachusetts, the US.

Fractyl Laboratories Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fractyl Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fractyl Laboratories Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fractyl Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fractyl Laboratories Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Fractyl Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fractyl Laboratories Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Fractyl Lab Raises USD44 Million in Series D Financing 10
Fractyl Laboratories Raises USD38.4 Million in Venture Financing 12
Fractyl Labs Raises Additional USD17 Million in Series C Financing 13
Fractyl Labs Raises USD40 Million in Series C Venture Financing 15
Fractyl Labs Raises US$14.3 Million In Venture Financing 16
Fractyl Laboratories Inc – Key Competitors 17
Fractyl Laboratories Inc – Key Employees 18
Fractyl Laboratories Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Fractyl Laboratories Inc, Medical Equipment, Key Facts 2
Fractyl Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fractyl Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fractyl Laboratories Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fractyl Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fractyl Laboratories Inc, Deals By Market, 2012 to YTD 2018 8
Fractyl Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fractyl Lab Raises USD44 Million in Series D Financing 10
Fractyl Laboratories Raises USD38.4 Million in Venture Financing 12
Fractyl Labs Raises Additional USD17 Million in Series C Financing 13
Fractyl Labs Raises USD40 Million in Series C Venture Financing 15
Fractyl Labs Raises US$14.3 Million In Venture Financing 16
Fractyl Laboratories Inc, Key Competitors 17
Fractyl Laboratories Inc, Key Employees 18

List of Figures
Fractyl Laboratories Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fractyl Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fractyl Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fractyl Laboratories Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fractyl Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fractyl Laboratories Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Fractyl Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fractyl Laboratories Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Fractyl Laboratories Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Itron Inc (ITRI):電力:M&Aディール及び事業提携情報
    Summary Itron Inc (Itron) is a technology and services company, which enables utilities and cities to provide critical infrastructure services. It offers solutions that help measure, manage and analyze energy and water use. The company’s solutions include metering systems, standard meters, next-gene …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nuformix Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Nuformix Ltd (Nuformix) is a provider of pharmaceutical cocrystallisation products. The company develops and manufactures products in reprofiling, supergenerics and emerging markets areas. It offers methodologies for rational solid form discovery; and provides technologies for rapid solid fo …
  • Swire Pacific Ltd:戦略・SWOT・企業財務分析
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shri Lakshmi Defence Solutions Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Defence Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Defence Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Renaissance Offshore LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Renaissance Offshore LLC (Renaissance Offshore) is an oil and gas exploration and development company. The company carries out the business of identification and acquisition of under-developed oil and gas assets in the Gulf of Mexico. It builds and manages a portfolio of assets on oil produc …
  • Mustek Limited (MST):企業の財務・戦略的SWOT分析
    Mustek Limited (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Xiangxue Pharmaceutical Co Ltd (300147):製薬・医療:M&Aディール及び事業提携情報
    Summary Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The company’s products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare suppleme …
  • Genentech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • Tana Exploration Company LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Tana Exploration Company LLC (Tana Exploration) is an oil and gas exploration and development company that develops oil and gas resources. The company's products include natural gas and crude oil. It provides services such as technical support, financial support, and remodeling services. Tan …
  • Novita Healthcare Ltd (NHL)-製薬・医療分野:企業M&A・提携分析
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Norsk Hydro ASA:企業のM&A・事業提携・投資動向
    Norsk Hydro ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norsk Hydro ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Wincanton Plc (WIN):企業の財務・戦略的SWOT分析
    Wincanton Plc (WIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hopewell Holdings Ltd:企業の戦略的SWOT分析
    Hopewell Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • YaSheng Group Ltd (HERB):企業の財務・戦略的SWOT分析
    Summary YaSheng Group Ltd (YaSheng) is a manufacturer of agriculture and package based products. The company operates through livestock, agriculture and biotechnology segments. YaSheng cultivates, processes, markets and distributes various food and agro-by products including field crops, fruits, veg …
  • Zealand Pharma AS (ZEAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …
  • Newfield Exploration Company (NFX)-石油・ガス分野:企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • DASAN ZHONE SOLUTIONS, INC.:企業の戦略・SWOT・財務情報
    DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report Summary DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Do & Co Poland Sp.Z.O.O:企業の戦略・SWOT・財務分析
    Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report Summary Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆